Work

Once-Monthly Maridebart Cafraglutide in Obesity — A Phase 2 Trial

Year: 2025

Type: article

Source: New England Journal of Medicine

DOI: 10.1056/nejmc2514331

Authors: Ania M Jastreboff, Donna H Ryan, Nicola Pannacciulli

Institutions: Yale University, Pennington Biomedical Research Center, Amgen (United States)

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417035694

FWCI: 0.493

Cites: 10

Cited by: 1

Related to: